LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Startup Investment Opportunities
Post Office Businesses for Sale
Convenience Stores & Lotto Businesses For Sale
Technology Businesses for Sale
Printing, Signs & Publishing Businesses for Sale
Vending & Kiosk Businesses for Sale
Hotels and Motels for Sale
Manufacturing Businesses for Sale
Entertainment & Recreation Businesses for Sale
Retail Businesses for Sale
Catering Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Advertising & Promotional Franchises for Sale
Pet Franchise Opportunities
Laundromat & Dry Cleaning Franchise Opportunities
Transport & Shipping Franchise Opportunities
Technology Franchise Opportunities
Home Based Franchise Opportunities
Finance & Accounting Franchise Opportunities
Gift & Flower Shop Franchise Opportunities
Commercial Buildings for Sale or Lease
Retail Buildings for Sale or Lease
Places of Worship for Sale
Houses & Condos for Sale or Lease
Miscellaneous Properties for Sale or Lease
Apartment Buildings for Sale
Medical Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
Retail Spaces for Lease or Sale
Commercial Spaces for Sale or Lease
An email will be sent to registered email address.
Please select if you are: